Cancer Treatment Reviews
Volume 27, Issue 5 , Pages 275-282, October 2001

Nipple discharge: current diagnostic and therapeutic approaches

Department of Surgery, 251 Hellenic Air Force Hospital, Athens

Abstract 

Nipple discharge is a complex diagnostic challenge for the clinician. A variety of diseases (such as intraductal papillomas, mammary duct ectasia, breast cancer, pituitary adenomas, breast abscesses/infections, etc.) can manifest as nipple discharge. The importance of nipple discharge for both the patient and the physician is the possible association of this condition with an underlying carcinoma. With heightened public awareness of breast cancer, an increasing number of women are asking their health care providers about nipple discharge. A detailed clinical evaluation is invaluable to determine the pathophysiology, assess the risk of malignancy, and plan treatment of the patient with nipple discharge. A combination of diagnostic tests, including mammography, breast ultrasonography, and possibly galactography can help the clinician to establish the diagnosis and plan proper management. Depending on the underlying breast pathology, a central or single lactiferous duct excision is the procedure of choice. Breast carcinoma associated with nipple discharge should be treated by either a modified radical mastectomy of breast-conservation therapy (i.e. duct-lobular segmentectomy with adequate, free margins [ideally>1cm], levels I and II axillary lymph node dissection, followed by breast irradiation).

Keywords: Breast cancer, mastectomy, duct excision, nipple discharge, galactorrhea

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 
  • f1 Correspondence to: George H. Sakorafas MD, Arkadias 19–21, GR-115 26 Athens, Greece, Tel: 001 301 74 87 318; Fax: 001 301 74 87 192; E-mail: georgesakorafas@yahoo.com

PII: S0305-7372(01)90234-8

doi:10.1053/ctrv.2001.0234

Cancer Treatment Reviews
Volume 27, Issue 5 , Pages 275-282, October 2001